COVID-19 Immune Response Appears Strong in Cancer Patients
FRIDAY, Aug. 20, 2021 (HealthDay News) — The seropositivity rate among patients with cancer...
Read More
Hematology/Oncology
An audit of gynae-oncology practices in ovarian cancer treatment based on enhanced recovery after surgery (ERAS) protocol amongst two gynae-oncology units, in UK and in Pakistan.
To compare peri-operative practices and complications in ovarian cancer patients undergoing...
Read More
Mutation spectrum of the NF1 gene and genotype-phenotype correlations in Turkish patients: Seventeen novel pathogenic variants.
Neurofibromatosis type 1 is one of the most common autosomal dominant diseases caused by...
Read More
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy.
P-glycoprotein (P-gp) is an adenosine triphosphate (ATP)-dependent drug efflux protein commonly...
Read More
FDA: Stop Using Eco-Med Ultrasound Gels, Lotions
THURSDAY, Aug. 19, 2021 (HealthDay News) — Health care providers and facilities should...
Read More
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
THURSDAY, Aug. 19, 2021 (HealthDay News) — For patients with clear-cell renal cell carcinoma...
Read More
Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL
THURSDAY, Aug. 19, 2021 (HealthDay News) — Previous treatment with anti-programmed cell...
Read More
High-Intensity Interval Training Beneficial in Prostate Cancer
THURSDAY, Aug. 19, 2021 (HealthDay News) — For men with low-risk to favorable...
Read More
Cannabis Use Lower in Cancer Survivors Than General Population
WEDNESDAY, Aug. 18, 2021 (HealthDay News) — Cancer survivors use cannabis at slightly lower...
Read More
COVID-19 Experiences Predicting High Anxiety and Depression Among a Sample of BRCA1/BRCA2-positive Women in the US.
During the COVID-19 pandemic, breast and ovarian cancer survivors experienced more anxiety and...
Read More
Non-invasive evaluation of HABP1 expression with Tc-labeled small-interference RNA in ovarian cancer.
Ovarian cancer is one of the most common gynecological cancers in women with a low 5-year survival...
Read More
LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial-mesenchymal transition.
Long non-coding RNA (lncRNA) is a newly identified regulator of tumor formation and tumor...
Read More
Model Predicts False-Positives in Breast Cancer MRI Screen
TUESDAY, Aug. 17, 2021 (HealthDay News) — For women with extremely dense breasts, prediction...
Read More
Minorities, Women Underrepresented in Pancreatic Cancer Trials
TUESDAY, Aug. 17, 2021 (HealthDay News) — Non-White, Hispanic, and female patients with...
Read More
Doctors More Likely to Test for Conditions Recently Diagnosed in Other Patients
TUESDAY, Aug. 17, 2021 (HealthDay News) — If an emergency medicine physician sees a...
Read More
Blacks Remain Underrepresented in U.S. Medical School Faculty
WEDNESDAY, Aug. 18, 2021 (HealthDay News) — From 1990 to 2020, there were only minimal...
Read More
Early-Onset CRC Biologically Similar to Average-Onset CRC
WEDNESDAY, Aug. 18, 2021 (HealthDay News) — Early-onset colorectal cancer (EO-CRC) appears...
Read More
COVID-19 Outcomes in Critically Ill No Better With Full-Dose Heparin
MONDAY, Aug. 16, 2021 (HealthDay News) — Therapeutic-dose anticoagulation with heparin does...
Read More
Age, Ethnicity Tied to Less Follow-Up Care in Childhood Cancer Survivors
MONDAY, Aug. 16, 2021 (HealthDay News) — Age and ethnic background are associated with...
Read More
Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report.
Mutation of BRCA2, a breast cancer susceptibility gene, is associated with the development of...
Read More